Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis

摘要

Allergic rhinitis (AR) affects an estimated 20% of the worldwide population. Allergic conjunctivitis, which often accompanies AR, has symptoms that include itching, tearing and redness. The nasal and ocular symptoms, when presented together, are referred to as allergic rhinoconjunctivitis. Oral antihistamines and intranasal corticosteroids (INSs) are prescribed for the treatment of allergic rhinoconjunctivitis; INSs have the potential effect of reducing ocular symptoms in patients with seasonal allergic conjunctivitis and to a lesser degree in patients with perennial allergic conjunctivitis, purportedly to a stronger degree than oral antihistamines, according to recent research. Read More: http://informahealthcare.com/doi/full/10.1185/03007991003715657